Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Julie Belliere »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Julie Barsalou < Julie Belliere < Julie Bruneau  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000031 (2020) Etienne Dufranc [France] ; Arnaud Del Bello [France] ; Julie Belliere [France] ; Nassim Kamar [France] ; Stanislas Faguer [France]IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
000357 (2016) Stanislas Faguer [France] ; François Vergez [France] ; Michael Peres [France] ; Inès Ferrandiz [France] ; Audrey Casemayou [France] ; Julie Belliere [France] ; Olivier Cointault [France] ; Laurence Lavayssiere [France] ; Marie-Béatrice Nogier [France] ; Grégoire Prevot [France] ; Antoine Huart [France] ; Christian Recher [France] ; Lionel Rostaing [France]Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T‐cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Humans
1Acute Kidney Injury (etiology)
1Acute Kidney Injury (therapy)
1Adult
1Antibodies, Monoclonal, Humanized
1Antibodies, Monoclonal, Humanized (administration & dosage)
1Antibodies, Monoclonal, Humanized (pharmacology)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Cell Division
1Critical Illness
1Cyclophosphamide (therapeutic use)
1Cytokines (blood)
1Drug Resistance
1Granzymes (analysis)
1Interleukin-6
1Killer Cells, Natural (drug effects)
1Killer Cells, Natural (immunology)
1Lymphocyte Activation
1Lymphocyte Count
1Lymphohistiocytosis, Hemophagocytic
1Lymphohistiocytosis, Hemophagocytic (blood)
1Lymphohistiocytosis, Hemophagocytic (complications)
1Lymphohistiocytosis, Hemophagocytic (drug therapy)
1Lymphohistiocytosis, Hemophagocytic (immunology)
1Male
1Methylprednisolone (therapeutic use)
1Middle Aged
1Renal Replacement Therapy
1Respiration, Artificial
1Respiratory Insufficiency (etiology)
1Respiratory Insufficiency (therapy)
1Salvage Therapy
1T-Lymphocyte Subsets (drug effects)
1T-Lymphocyte Subsets (enzymology)
1T-Lymphocyte Subsets (immunology)
1T-Lymphocytes, Cytotoxic (drug effects)
1T-Lymphocytes, Cytotoxic (enzymology)
1T-Lymphocytes, Cytotoxic (immunology)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Julie Belliere" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Julie Belliere" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Julie Belliere
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021